Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Thyroid : Official Journal of the American Thyroid Association
|
March 6, 2026
Evaluating Artificial Intelligence Chatbots for Patient Education on Thyroid Radiofrequency Ablation: An Analysis of Accuracy, Quality, and Readability
Jacob Beiriger, Leonard E Estephan, Daniel Campbell, et al.
Cell Metabolism
|
August 22, 2024
Misregulation of mitochondrial 6mA promotes the propagation of mutant mtDNA and causes aging in C. elegans
Anne Hahn, Grace Ching Ching Hung, Arnaud Ahier, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 24, 2020
A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation
Jane C Davies, Isabelle Sermet-Gaudelus, Lutz Naehrlich, et al.
Scientific Reports
|
June 21, 2024
The impact of astrocytic NF-κB on healthy and Alzheimer's disease brains
Tee Jong Huat, Judith Camats-Perna, Estella A Newcombe, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 15, 2019
Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries
Nataliya Volkova, Kristin Moy, Jennifer Evans, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
July 3, 2024
Obesity and Survival After Immune Checkpoint Inhibition for Head and Neck Squamous Cell Carcinoma
Eric V Mastrolonardo, Pablo Llerena, Joseph Lu, et al.
Elife
|
September 20, 2024
Dynamic chromatin architecture identifies new autoimmune-associated enhancers for <i>IL2</i> and novel genes regulating CD4+ T cell activation
Matthew C Pahl, Prabhat Sharma, Rajan M Thomas, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 22, 2022
A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variant
Gregory S Sawicki, Mark Chilvers, John McNamara, et al.
Physical Review Letters
|
May 4, 2019
Unconventional Charge Density Wave Order in the Pnictide Superconductor Ba(Ni_{1-x}Co_{x})_{2}As_{2}
Sangjun Lee, Gilberto de la Peña, Stella X-L Sun, et al.
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Defects in CD8 <sup>+</sup> T cell suppression by Foxp3-ΔE2 expressing regulatory T cells
Kristin N Weinstein, Zoe H Bishop, Elya A Shamskhou, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Thyroid : Official Journal of the American Thyroid Association
|
March 6, 2026
Evaluating Artificial Intelligence Chatbots for Patient Education on Thyroid Radiofrequency Ablation: An Analysis of Accuracy, Quality, and Readability
Jacob Beiriger, Leonard E Estephan, Daniel Campbell, et al.
Cell Metabolism
|
August 22, 2024
Misregulation of mitochondrial 6mA promotes the propagation of mutant mtDNA and causes aging in C. elegans
Anne Hahn, Grace Ching Ching Hung, Arnaud Ahier, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 24, 2020
A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation
Jane C Davies, Isabelle Sermet-Gaudelus, Lutz Naehrlich, et al.
Scientific Reports
|
June 21, 2024
The impact of astrocytic NF-κB on healthy and Alzheimer's disease brains
Tee Jong Huat, Judith Camats-Perna, Estella A Newcombe, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 15, 2019
Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries
Nataliya Volkova, Kristin Moy, Jennifer Evans, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
July 3, 2024
Obesity and Survival After Immune Checkpoint Inhibition for Head and Neck Squamous Cell Carcinoma
Eric V Mastrolonardo, Pablo Llerena, Joseph Lu, et al.
Elife
|
September 20, 2024
Dynamic chromatin architecture identifies new autoimmune-associated enhancers for <i>IL2</i> and novel genes regulating CD4+ T cell activation
Matthew C Pahl, Prabhat Sharma, Rajan M Thomas, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 22, 2022
A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variant
Gregory S Sawicki, Mark Chilvers, John McNamara, et al.
Physical Review Letters
|
May 4, 2019
Unconventional Charge Density Wave Order in the Pnictide Superconductor Ba(Ni_{1-x}Co_{x})_{2}As_{2}
Sangjun Lee, Gilberto de la Peña, Stella X-L Sun, et al.
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Defects in CD8 <sup>+</sup> T cell suppression by Foxp3-ΔE2 expressing regulatory T cells
Kristin N Weinstein, Zoe H Bishop, Elya A Shamskhou, et al.
Page
of 7